# Metformin Combined With Chemotherapy for Pancreatic Cancer

> **NCT01210911** · PHASE2 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 120 (actual)

## Conditions studied

- Locally Advanced Pancreatic Cancer
- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** erlotinib
- **DRUG:** metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01210911
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210911, "Metformin Combined With Chemotherapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01210911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*